Steroid avoidance in renal transplant patients maintained on a cyclosporine-based protocol

Experimental and Clinical Transplantation

Volumn 5, Issue 2, 2007, Pages 664-669

  Ko, Tina Y ^a   Haddy, Julie A ^a   Marcus, Richard J ^a   Carpenter, Barbara J ^a   Nghiem, Dai D ^a   McGill, Rita L ^a   Sandroni, Stephen E ^a   Patel, Satish ^a   Breckenridge, Molly ^a   Sureshkumar, Kalathil K ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Acute rejection; Kidney; Leukopenia; Steroid free; Transplantation

Indexed keywords

ACICLOVIR; BASILIXIMAB; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE PERIOD; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WEIGHT GAIN;

AGED; CYCLOSPORINE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 38549106102     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002;346(8):580-590.
2. Kuypers DR, Vanrentergnem YC. Tailoring immunosuppressive therapy. Nephrol Dial Transplant. 2002;17(12):2051-2054.
3. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol. 2000; 11(10): 1910-1917.
4. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol. 1993;4(6):1300-1305.
5. Kumar MS, Xiao SG, Fyfe B, et al. Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies. Clin Transplant. 2005; 19(1):61-69.
6. Ahsan N, Hricik D, Matas A, et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Steroid Withdrawal Study Group. Transplantation. 1999;68(12):1865-1874.
7. Vincenti-F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant. 2003;3(3):306-311.
8. ter Meulen CG, van Riemsdijk I, Hend RJ, et al. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. Am J Transplant. 2004;4(5):803-810.
9. Teraoka S, Sato S, Sekijima M, et al. Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid. Transplant Proc. 2005;37(2):791-794.
10. Land W, Vincenti F. Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation. Transplantation. 2005;80(2 Suppl):S221-S234.
11. Sivaraman P, Nussbaumer G, Landsberg D. Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis. 2001 37(6):1162-1169.
12. Rogers CC, Alloway RR, Hanaway M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplant Proc. 2005;37(2):800-801.
13. Smak Gregoor PJ, de Sévaux RG, Ligtenberg G, et al. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. J Am Soc Nephrol. 2002;13(5):1365-1373.
14. Rostaing L, Cantarovich D, Mourad G, et al. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation. 2005;79(7):807-814.
15. Oertel M, Sack U, Kohlhaw K, et al. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study. Transpl Int. 2002; 15(9-10):463-471.